Fibromyalgia Research-2016 Jul

in 2016, Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes

BACKGROUND: The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin.

You can read the full article here => http://online.liebertpub.com/doi/abs/10.1089/can.2016.0009